These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Interferon studies at the Wisconsin Clinical Cancer Center. Buchanan-Davidson DJ Wis Med J; 1980 Sep; 79(9):35. PubMed ID: 6158802 [No Abstract] [Full Text] [Related]
49. Interferon: an early evaluation. McCredie KB; Moore MS J Okla State Med Assoc; 1980 Sep; 73(9):325-8. PubMed ID: 6160226 [No Abstract] [Full Text] [Related]
50. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review. Wadler S; Schwartz EL Cancer Res; 1990 Jun; 50(12):3473-86. PubMed ID: 1692761 [TBL] [Abstract][Full Text] [Related]
51. [Use of interferons and interferonogens in dermatology (a review)]. Shcherbakov IM Vestn Dermatol Venerol; 1973 Mar; 47(3):8-13. PubMed ID: 4581062 [No Abstract] [Full Text] [Related]
52. [Effect of interferon on experimental herpes simplex virus infections (author's transl)]. Kurachi N; Takeyama H; Nagata I Uirusu; 1976 Jul; 26(1-2):20-5. PubMed ID: 1036127 [No Abstract] [Full Text] [Related]
54. [Interferon: facts and hopes. II. Interferon treatment]. Dmoszyńska-Giannopoulou A; Rupniewska ZM Pol Arch Med Wewn; 1981 Oct; 66(4):307-11. PubMed ID: 6174954 [No Abstract] [Full Text] [Related]
55. Interferons and rabies. Vella W Br Med J; 1977 Jun; 1(6074):1470. PubMed ID: 861698 [No Abstract] [Full Text] [Related]
56. Interferon in cancer: Faith, hope and reality. Strander H; Einhorn S Am J Clin Oncol; 1982 Jun; 5(3):297-301. PubMed ID: 6177233 [TBL] [Abstract][Full Text] [Related]
57. The interferon-cancer trials: hardly hopeless but not too heartening. Hager T JAMA; 1983 Aug; 250(8):1007-10. PubMed ID: 6192259 [No Abstract] [Full Text] [Related]